 Todd Kingdom
Concepts (350)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sinusitis | 25 | 2021 | 227 | 3.530 |
Why?
| | Rhinitis | 23 | 2023 | 169 | 3.260 |
Why?
| | Nasal Polyps | 15 | 2017 | 59 | 2.910 |
Why?
| | Endoscopy | 21 | 2024 | 317 | 2.570 |
Why?
| | Paranasal Sinuses | 13 | 2017 | 81 | 1.800 |
Why?
| | Paranasal Sinus Neoplasms | 9 | 2026 | 29 | 1.730 |
Why?
| | Dacryocystorhinostomy | 3 | 2020 | 13 | 1.010 |
Why?
| | Surgery, Computer-Assisted | 3 | 2015 | 85 | 0.950 |
Why?
| | Nasal Mucosa | 6 | 2019 | 112 | 0.920 |
Why?
| | Skull Base | 6 | 2023 | 55 | 0.850 |
Why?
| | Aspirin | 6 | 2016 | 406 | 0.810 |
Why?
| | Cystic Fibrosis | 7 | 2014 | 1161 | 0.700 |
Why?
| | Orbit | 4 | 2016 | 66 | 0.670 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 3 | 2015 | 345 | 0.560 |
Why?
| | Lipoxygenase | 2 | 2008 | 15 | 0.520 |
Why?
| | Chronic Disease | 19 | 2023 | 1808 | 0.520 |
Why?
| | Postoperative Complications | 7 | 2018 | 2970 | 0.510 |
Why?
| | Sphenoid Sinus | 2 | 2009 | 7 | 0.500 |
Why?
| | Asthma, Aspirin-Induced | 1 | 2015 | 3 | 0.460 |
Why?
| | Decompression, Surgical | 2 | 2017 | 116 | 0.450 |
Why?
| | Graves Ophthalmopathy | 1 | 2015 | 13 | 0.440 |
Why?
| | Paranasal Sinus Diseases | 3 | 2017 | 15 | 0.420 |
Why?
| | Quality of Life | 7 | 2026 | 3204 | 0.400 |
Why?
| | Protein Array Analysis | 2 | 2011 | 56 | 0.370 |
Why?
| | Eosinophilia | 3 | 2016 | 223 | 0.360 |
Why?
| | Respiratory System | 1 | 2013 | 150 | 0.360 |
Why?
| | Bronchiectasis | 1 | 2013 | 115 | 0.350 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 26 | 0.350 |
Why?
| | Middle Aged | 35 | 2026 | 36215 | 0.350 |
Why?
| | Sputum | 1 | 2013 | 302 | 0.340 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 239 | 0.340 |
Why?
| | Rhinitis, Allergic | 4 | 2021 | 42 | 0.340 |
Why?
| | Chemokine CCL5 | 1 | 2011 | 40 | 0.330 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 131 | 0.330 |
Why?
| | Evidence-Based Medicine | 5 | 2016 | 740 | 0.320 |
Why?
| | Tomography, X-Ray Computed | 15 | 2018 | 2769 | 0.320 |
Why?
| | Immunotherapy | 1 | 2015 | 666 | 0.320 |
Why?
| | Humans | 73 | 2026 | 145474 | 0.320 |
Why?
| | Cyclooxygenase 1 | 2 | 2008 | 27 | 0.310 |
Why?
| | Frontal Sinus | 2 | 2007 | 6 | 0.310 |
Why?
| | Adult | 34 | 2026 | 40777 | 0.300 |
Why?
| | Cerebrospinal Fluid Rhinorrhea | 3 | 2022 | 10 | 0.300 |
Why?
| | Surgical Flaps | 3 | 2019 | 142 | 0.300 |
Why?
| | Leiomyosarcoma | 1 | 2009 | 29 | 0.300 |
Why?
| | Cyclooxygenase 2 | 2 | 2008 | 166 | 0.290 |
Why?
| | Mycoses | 3 | 2005 | 88 | 0.280 |
Why?
| | Odontoma | 1 | 2008 | 4 | 0.280 |
Why?
| | Maxillary Sinus Neoplasms | 1 | 2008 | 6 | 0.280 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2008 | 75 | 0.280 |
Why?
| | Aged | 26 | 2026 | 26153 | 0.270 |
Why?
| | Male | 42 | 2026 | 72842 | 0.270 |
Why?
| | Retrospective Studies | 22 | 2022 | 17291 | 0.270 |
Why?
| | Treatment Outcome | 15 | 2024 | 11772 | 0.270 |
Why?
| | Head and Neck Neoplasms | 3 | 2024 | 561 | 0.260 |
Why?
| | Immunoglobulin E | 2 | 2018 | 315 | 0.260 |
Why?
| | Female | 39 | 2026 | 78844 | 0.240 |
Why?
| | Minimal Clinically Important Difference | 1 | 2026 | 31 | 0.240 |
Why?
| | Consensus | 3 | 2021 | 477 | 0.240 |
Why?
| | Nose Neoplasms | 2 | 1996 | 22 | 0.230 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2007 | 124 | 0.230 |
Why?
| | Practice Guidelines as Topic | 2 | 2014 | 1581 | 0.220 |
Why?
| | Cranial Fossa, Posterior | 2 | 2012 | 20 | 0.220 |
Why?
| | Hypersensitivity | 3 | 2024 | 254 | 0.210 |
Why?
| | Osteomyelitis | 1 | 2007 | 145 | 0.210 |
Why?
| | Streptococcus | 1 | 2004 | 29 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 2 | 2016 | 134 | 0.210 |
Why?
| | Prednisone | 2 | 2017 | 224 | 0.210 |
Why?
| | Staphylococcus | 1 | 2004 | 74 | 0.210 |
Why?
| | Gram-Negative Bacteria | 1 | 2004 | 80 | 0.200 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 4 | 2011 | 38 | 0.200 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2003 | 17 | 0.200 |
Why?
| | Adenoma | 2 | 2018 | 218 | 0.200 |
Why?
| | Skull Base Neoplasms | 1 | 2023 | 30 | 0.190 |
Why?
| | Bone Diseases | 1 | 2003 | 61 | 0.190 |
Why?
| | Aged, 80 and over | 11 | 2024 | 8333 | 0.180 |
Why?
| | Prospective Studies | 7 | 2026 | 8057 | 0.170 |
Why?
| | Reoperation | 3 | 2019 | 633 | 0.170 |
Why?
| | Laryngeal Diseases | 2 | 2003 | 31 | 0.170 |
Why?
| | Pseudomonas aeruginosa | 4 | 2014 | 395 | 0.170 |
Why?
| | Adolescent | 14 | 2019 | 22529 | 0.170 |
Why?
| | Glucocorticoids | 2 | 2017 | 531 | 0.170 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2020 | 11 | 0.160 |
Why?
| | Nasolacrimal Duct | 1 | 2020 | 12 | 0.160 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1508 | 0.150 |
Why?
| | Sphenoid Sinusitis | 1 | 2018 | 4 | 0.150 |
Why?
| | Sella Turcica | 1 | 2018 | 17 | 0.140 |
Why?
| | Polyethylenes | 1 | 2018 | 12 | 0.140 |
Why?
| | Nasal Septum | 2 | 2020 | 30 | 0.140 |
Why?
| | Up-Regulation | 2 | 2012 | 847 | 0.140 |
Why?
| | Parotid Diseases | 1 | 1998 | 3 | 0.140 |
Why?
| | Ethmoid Sinus | 2 | 2015 | 6 | 0.140 |
Why?
| | Sclerosing Solutions | 1 | 1998 | 10 | 0.140 |
Why?
| | Sclerotherapy | 1 | 1998 | 19 | 0.140 |
Why?
| | Otolaryngology | 2 | 2011 | 108 | 0.140 |
Why?
| | Immunohistochemistry | 3 | 2009 | 1716 | 0.140 |
Why?
| | Doxycycline | 1 | 1998 | 62 | 0.140 |
Why?
| | Vision Disorders | 2 | 2017 | 179 | 0.130 |
Why?
| | Immunoglobulin D | 1 | 2017 | 29 | 0.130 |
Why?
| | Prostheses and Implants | 1 | 2018 | 137 | 0.130 |
Why?
| | Mucocele | 1 | 2017 | 12 | 0.130 |
Why?
| | Cysts | 1 | 1998 | 112 | 0.130 |
Why?
| | Melanoma | 2 | 1995 | 759 | 0.130 |
Why?
| | Pituitary Neoplasms | 1 | 2018 | 190 | 0.120 |
Why?
| | Follow-Up Studies | 4 | 2015 | 5423 | 0.120 |
Why?
| | Aspergillosis | 1 | 1996 | 24 | 0.120 |
Why?
| | Aspergillus fumigatus | 1 | 1996 | 26 | 0.120 |
Why?
| | Rhinitis, Allergic, Perennial | 2 | 2013 | 20 | 0.120 |
Why?
| | Neuroendoscopy | 1 | 2016 | 24 | 0.120 |
Why?
| | Graves Disease | 1 | 2016 | 32 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 68 | 0.120 |
Why?
| | Th1-Th2 Balance | 1 | 2015 | 8 | 0.120 |
Why?
| | Visual Acuity | 2 | 2017 | 491 | 0.110 |
Why?
| | Superantigens | 1 | 2015 | 70 | 0.110 |
Why?
| | Forced Expiratory Volume | 2 | 2014 | 450 | 0.110 |
Why?
| | Pharynx | 1 | 1995 | 59 | 0.110 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1996 | 130 | 0.110 |
Why?
| | Nasopharynx | 1 | 2015 | 72 | 0.110 |
Why?
| | Mouth | 1 | 1995 | 86 | 0.110 |
Why?
| | Neck | 3 | 2005 | 108 | 0.110 |
Why?
| | Dinoprostone | 1 | 2015 | 180 | 0.110 |
Why?
| | Meningitis | 1 | 2016 | 80 | 0.110 |
Why?
| | Nasal Cavity | 1 | 1995 | 61 | 0.110 |
Why?
| | Biocompatible Materials | 1 | 2018 | 429 | 0.110 |
Why?
| | Actinomycosis | 1 | 1994 | 5 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2016 | 157 | 0.110 |
Why?
| | Young Adult | 8 | 2018 | 14218 | 0.100 |
Why?
| | Nose Diseases | 1 | 1994 | 17 | 0.100 |
Why?
| | Radiotherapy, Adjuvant | 1 | 1995 | 222 | 0.100 |
Why?
| | Microbiota | 3 | 2018 | 730 | 0.100 |
Why?
| | Neurosurgical Procedures | 1 | 2016 | 202 | 0.100 |
Why?
| | Angiofibroma | 1 | 2013 | 6 | 0.100 |
Why?
| | Pituitary Diseases | 1 | 2013 | 20 | 0.100 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2013 | 21 | 0.100 |
Why?
| | Cervical Vertebrae | 1 | 1995 | 168 | 0.100 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 409 | 0.100 |
Why?
| | Case-Control Studies | 5 | 2017 | 3623 | 0.100 |
Why?
| | HIV Seropositivity | 1 | 1994 | 119 | 0.100 |
Why?
| | Cerebellopontine Angle | 1 | 1993 | 7 | 0.100 |
Why?
| | Biopsy | 3 | 2017 | 1082 | 0.100 |
Why?
| | Granulocytes | 1 | 2013 | 81 | 0.100 |
Why?
| | bcl-X Protein | 1 | 2012 | 45 | 0.090 |
Why?
| | Chemoreceptor Cells | 1 | 2013 | 50 | 0.090 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 474 | 0.090 |
Why?
| | Biofilms | 1 | 2015 | 292 | 0.090 |
Why?
| | Microarray Analysis | 1 | 2012 | 116 | 0.090 |
Why?
| | Vital Capacity | 1 | 2013 | 292 | 0.090 |
Why?
| | TRPM Cation Channels | 1 | 2013 | 73 | 0.090 |
Why?
| | Skull Neoplasms | 1 | 2012 | 21 | 0.090 |
Why?
| | Neoplasms, Second Primary | 2 | 2012 | 102 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 286 | 0.090 |
Why?
| | Histocytochemistry | 1 | 2011 | 78 | 0.090 |
Why?
| | Cerebrospinal Fluid Leak | 3 | 2022 | 70 | 0.090 |
Why?
| | Pituitary Gland | 1 | 2012 | 149 | 0.080 |
Why?
| | Cerebellar Neoplasms | 1 | 1993 | 177 | 0.080 |
Why?
| | Incidence | 2 | 2015 | 2923 | 0.080 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2014 | 371 | 0.080 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2013 | 1149 | 0.080 |
Why?
| | Bacteria | 1 | 2016 | 765 | 0.080 |
Why?
| | Vasoconstrictor Agents | 1 | 2011 | 150 | 0.080 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 408 | 0.080 |
Why?
| | Adaptor Protein Complex beta Subunits | 1 | 2009 | 2 | 0.070 |
Why?
| | Caspase 8 | 1 | 2009 | 47 | 0.070 |
Why?
| | Caspase 9 | 1 | 2009 | 55 | 0.070 |
Why?
| | Epistaxis | 3 | 2011 | 17 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2009 | 185 | 0.070 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2009 | 75 | 0.070 |
Why?
| | Drug Tolerance | 1 | 2009 | 99 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 6 | 2013 | 3904 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 848 | 0.070 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2008 | 17 | 0.070 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2008 | 20 | 0.070 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2008 | 37 | 0.070 |
Why?
| | Blotting, Western | 1 | 2011 | 1179 | 0.070 |
Why?
| | Maxilla | 1 | 2007 | 36 | 0.070 |
Why?
| | Child | 9 | 2016 | 22707 | 0.060 |
Why?
| | Databases as Topic | 1 | 2007 | 71 | 0.060 |
Why?
| | Fellowships and Scholarships | 1 | 2011 | 354 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2026 | 2953 | 0.060 |
Why?
| | Reference Values | 1 | 2008 | 798 | 0.060 |
Why?
| | Arnold-Chiari Malformation | 2 | 1997 | 29 | 0.060 |
Why?
| | Child, Preschool | 5 | 2011 | 11853 | 0.060 |
Why?
| | Education, Medical, Graduate | 1 | 2011 | 562 | 0.060 |
Why?
| | Asthma | 2 | 2016 | 1797 | 0.060 |
Why?
| | Statistics, Nonparametric | 1 | 2006 | 428 | 0.060 |
Why?
| | Linear Models | 1 | 2007 | 845 | 0.050 |
Why?
| | Disease Progression | 1 | 2012 | 2864 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1923 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 6066 | 0.050 |
Why?
| | Fungi | 1 | 2005 | 121 | 0.050 |
Why?
| | Risk Assessment | 2 | 2013 | 3747 | 0.050 |
Why?
| | Pharyngeal Diseases | 1 | 2003 | 17 | 0.050 |
Why?
| | Mutation | 1 | 2014 | 4075 | 0.050 |
Why?
| | Mouth Diseases | 1 | 2003 | 47 | 0.050 |
Why?
| | Drug Resistance, Bacterial | 1 | 2004 | 185 | 0.050 |
Why?
| | Microbial Sensitivity Tests | 1 | 2004 | 364 | 0.050 |
Why?
| | Acute Disease | 2 | 2016 | 1036 | 0.050 |
Why?
| | HIV Infections | 1 | 1998 | 3193 | 0.050 |
Why?
| | Stroke | 1 | 2012 | 1270 | 0.050 |
Why?
| | Streptococcus pneumoniae | 1 | 2004 | 184 | 0.050 |
Why?
| | Antifungal Agents | 1 | 2003 | 151 | 0.050 |
Why?
| | Equipment Design | 1 | 2004 | 525 | 0.050 |
Why?
| | United States | 3 | 2015 | 16098 | 0.040 |
Why?
| | Head | 1 | 2003 | 121 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2121 | 0.040 |
Why?
| | Immunocompromised Host | 1 | 2003 | 202 | 0.040 |
Why?
| | Vocal Cord Paralysis | 2 | 1998 | 27 | 0.040 |
Why?
| | Ecchymosis | 1 | 2000 | 4 | 0.040 |
Why?
| | Mitomycin | 1 | 2020 | 32 | 0.040 |
Why?
| | Postoperative Period | 1 | 2022 | 351 | 0.040 |
Why?
| | Genotype | 2 | 2014 | 1852 | 0.040 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2001 | 122 | 0.040 |
Why?
| | Orbital Diseases | 1 | 2000 | 37 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2022 | 202 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2004 | 451 | 0.040 |
Why?
| | Absorbable Implants | 1 | 2020 | 38 | 0.040 |
Why?
| | Drug Implants | 1 | 2020 | 83 | 0.040 |
Why?
| | Meningioma | 1 | 2001 | 88 | 0.040 |
Why?
| | Signal Transduction | 1 | 2012 | 5216 | 0.040 |
Why?
| | Hypopharyngeal Neoplasms | 1 | 1998 | 4 | 0.040 |
Why?
| | Tracheal Neoplasms | 1 | 1998 | 12 | 0.040 |
Why?
| | Laryngeal Neoplasms | 1 | 1998 | 36 | 0.030 |
Why?
| | Bacterial Infections | 1 | 2000 | 246 | 0.030 |
Why?
| | Nasal Decongestants | 1 | 2018 | 9 | 0.030 |
Why?
| | Larynx | 1 | 1998 | 56 | 0.030 |
Why?
| | Histamine Antagonists | 1 | 2018 | 21 | 0.030 |
Why?
| | Skin Tests | 1 | 2018 | 94 | 0.030 |
Why?
| | Epidemiologic Methods | 1 | 2018 | 91 | 0.030 |
Why?
| | Syndecan-1 | 1 | 2017 | 43 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 195 | 0.030 |
Why?
| | Probiotics | 1 | 2018 | 61 | 0.030 |
Why?
| | Plasma Cells | 1 | 2017 | 79 | 0.030 |
Why?
| | Mucus | 1 | 2017 | 75 | 0.030 |
Why?
| | Complementary Therapies | 1 | 2018 | 95 | 0.030 |
Why?
| | Carcinoma | 1 | 1998 | 225 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2930 | 0.030 |
Why?
| | Physical Examination | 1 | 2018 | 243 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 265 | 0.030 |
Why?
| | Neoplasm Invasiveness | 2 | 2013 | 506 | 0.030 |
Why?
| | Immunoglobulin A | 1 | 2017 | 214 | 0.030 |
Why?
| | Candidiasis | 1 | 1996 | 64 | 0.030 |
Why?
| | Chemokines | 1 | 2017 | 217 | 0.030 |
Why?
| | Occupational Diseases | 1 | 2018 | 165 | 0.030 |
Why?
| | Chondrocalcinosis | 1 | 1995 | 1 | 0.030 |
Why?
| | Ossification of Posterior Longitudinal Ligament | 1 | 1995 | 2 | 0.030 |
Why?
| | Perioperative Period | 1 | 2016 | 70 | 0.030 |
Why?
| | Giant Cell Tumors | 1 | 1995 | 4 | 0.030 |
Why?
| | Odontoid Process | 1 | 1995 | 6 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2017 | 207 | 0.030 |
Why?
| | Atlanto-Axial Joint | 1 | 1995 | 12 | 0.030 |
Why?
| | Surgical Wound Dehiscence | 1 | 1995 | 22 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 67 | 0.030 |
Why?
| | Chondrosarcoma | 1 | 1995 | 17 | 0.030 |
Why?
| | Length of Stay | 1 | 2022 | 1349 | 0.030 |
Why?
| | Chordoma | 1 | 1995 | 17 | 0.030 |
Why?
| | Spinal Neoplasms | 1 | 1995 | 37 | 0.030 |
Why?
| | Water Microbiology | 1 | 2016 | 85 | 0.030 |
Why?
| | Spinal Diseases | 1 | 1995 | 50 | 0.030 |
Why?
| | Hemorrhage | 1 | 2000 | 822 | 0.030 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 322 | 0.030 |
Why?
| | Joint Dislocations | 1 | 1995 | 60 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2016 | 182 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 1044 | 0.030 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1996 | 237 | 0.030 |
Why?
| | Joint Diseases | 1 | 1995 | 65 | 0.030 |
Why?
| | Tracheostomy | 1 | 1996 | 142 | 0.030 |
Why?
| | Allergens | 1 | 2018 | 386 | 0.030 |
Why?
| | Drug Hypersensitivity | 1 | 2016 | 90 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 484 | 0.030 |
Why?
| | Postoperative Hemorrhage | 1 | 1995 | 105 | 0.030 |
Why?
| | Sweat | 1 | 2014 | 51 | 0.030 |
Why?
| | Biological Products | 1 | 2018 | 257 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2015 | 5904 | 0.030 |
Why?
| | Thyroid Neoplasms | 1 | 1998 | 350 | 0.030 |
Why?
| | Esophageal Neoplasms | 1 | 1998 | 348 | 0.030 |
Why?
| | Nutritional Status | 1 | 1996 | 353 | 0.030 |
Why?
| | Lung Diseases | 1 | 2000 | 780 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2016 | 507 | 0.030 |
Why?
| | Chlorides | 1 | 2014 | 138 | 0.020 |
Why?
| | Vestibulocochlear Nerve | 1 | 1993 | 7 | 0.020 |
Why?
| | Facial Nerve | 1 | 1993 | 39 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1323 | 0.020 |
Why?
| | Environmental Exposure | 1 | 2018 | 578 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2017 | 892 | 0.020 |
Why?
| | Phospholipase C beta | 1 | 2013 | 30 | 0.020 |
Why?
| | Cranial Nerve Diseases | 1 | 1993 | 44 | 0.020 |
Why?
| | Reproducibility of Results | 2 | 2003 | 3413 | 0.020 |
Why?
| | Transducin | 1 | 2013 | 42 | 0.020 |
Why?
| | Perioperative Care | 1 | 2015 | 231 | 0.020 |
Why?
| | Drug Resistance | 1 | 2013 | 145 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2013 | 330 | 0.020 |
Why?
| | Angiography | 1 | 2013 | 208 | 0.020 |
Why?
| | Olfaction Disorders | 1 | 2013 | 70 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1476 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 1995 | 325 | 0.020 |
Why?
| | Laryngoscopy | 1 | 2013 | 119 | 0.020 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 230 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 329 | 0.020 |
Why?
| | Epithelium | 1 | 2013 | 310 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 2013 | 175 | 0.020 |
Why?
| | Risk Factors | 2 | 2018 | 10885 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2013 | 767 | 0.020 |
Why?
| | Hematoma | 1 | 2011 | 63 | 0.020 |
Why?
| | Phenylephrine | 1 | 2011 | 74 | 0.020 |
Why?
| | Eosinophils | 1 | 2013 | 316 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2011 | 113 | 0.020 |
Why?
| | Data Collection | 1 | 2013 | 640 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 231 | 0.020 |
Why?
| | Administration, Topical | 1 | 2011 | 153 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2013 | 554 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 1993 | 1266 | 0.020 |
Why?
| | Survival Rate | 1 | 1995 | 2090 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1374 | 0.020 |
Why?
| | Animals | 1 | 2012 | 38030 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 2067 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1767 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2013 | 1041 | 0.020 |
Why?
| | Precision Medicine | 1 | 2014 | 459 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1162 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1471 | 0.020 |
Why?
| | Workload | 1 | 2011 | 168 | 0.020 |
Why?
| | Societies, Medical | 1 | 2013 | 899 | 0.020 |
Why?
| | Career Choice | 1 | 2011 | 234 | 0.020 |
Why?
| | Down Syndrome | 1 | 1995 | 525 | 0.020 |
Why?
| | Logistic Models | 1 | 2013 | 2134 | 0.020 |
Why?
| | Residence Characteristics | 1 | 2011 | 375 | 0.020 |
Why?
| | Pain | 1 | 2013 | 789 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 1995 | 1180 | 0.010 |
Why?
| | Biomarkers | 1 | 2017 | 4295 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 1993 | 849 | 0.010 |
Why?
| | Frontal Sinusitis | 1 | 2005 | 3 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2011 | 1061 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2012 | 978 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1371 | 0.010 |
Why?
| | Lung | 1 | 1996 | 4106 | 0.010 |
Why?
| | Postoperative Care | 1 | 2005 | 286 | 0.010 |
Why?
| | Cohort Studies | 1 | 2013 | 6013 | 0.010 |
Why?
| | Clinical Competence | 1 | 2011 | 1243 | 0.010 |
Why?
| | Facial Pain | 1 | 2001 | 12 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2005 | 645 | 0.010 |
Why?
| | Exophthalmos | 1 | 2001 | 18 | 0.010 |
Why?
| | Nasal Obstruction | 1 | 2001 | 26 | 0.010 |
Why?
| | Masks | 1 | 2001 | 70 | 0.010 |
Why?
| | Phantoms, Imaging | 1 | 2001 | 159 | 0.010 |
Why?
| | Headache | 1 | 2001 | 151 | 0.010 |
Why?
| | Radiography, Interventional | 1 | 2001 | 128 | 0.010 |
Why?
| | Laryngectomy | 1 | 1998 | 17 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2003 | 1997 | 0.010 |
Why?
| | Infant | 1 | 2011 | 10077 | 0.010 |
Why?
| | Radiosurgery | 1 | 2001 | 399 | 0.010 |
Why?
| | Algorithms | 1 | 1998 | 1845 | 0.000 |
Why?
|
|
Kingdom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|